Skip to main content
GRCE logo

GRCE

Grace Therapeutics, Inc.
$2.37 +0.13 (+5.80%) At close · Jul 2
Market Cap
$38.57M
Shares
16,274,026

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 35
Total Value: $20,266,757
Total Shares: 4,377,272

Institutional Ownership Trend

7 quarters

Holder Concentration

Across 35 13F filers · Δ vs Dec 31, 2025
Top Holder
19.4%
Sep 2024 → Mar 2026 · range 19.4% – 100.0%
−7.8 pts
Top 5
73.8%
Sep 2024 → Mar 2026 · range 73.8% – 100.0%
−10.5 pts
Top 10
90.1%
Sep 2024 → Mar 2026 · range 90.1% – 100.0%
−9.2 pts
HHI
1,237
Sep 2024 → Mar 2026 · range 1,237 – 10,000
Broadly held−497

Quarterly Activity

vs Dec 31, 2025
New
19
Increased
6
Decreased
4
Sold Out
6
Unchanged
6
Holder count: +13
Institutional value: +35.4%
Shares held: +1.1%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 36 of 36
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1444192 CUSIP 00439U104